Renal artery stenosis history and symptoms: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Resistant hypertension and a decrease in eGFR in a patient known to have atherosclerosis are 3 elements that are very important to raise the suspicion of | Resistant hypertension and a decrease in estimated [[glomerular filtration rate]] (eGFR) in a patient known to have [[atherosclerosis]] are 3 elements that are very important to raise the suspicion of atherosclerotic renal artery stenosis. Other factors, such as [[hypertension]] at an early age or [[malignant hypertension]], play a major role as well. | ||
==History and symptoms== | ==History and symptoms== | ||
| Line 24: | Line 24: | ||
Additional clinical clues that suggest renal artery disease are listed below<ref name="pmid15114537">{{cite journal| author=Kidney Disease Outcomes Quality Initiative (K/DOQI)| title=K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. | journal=Am J Kidney Dis | year= 2004 | volume= 43 | issue= 5 Suppl 1 | pages= S1-290 | pmid=15114537 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15114537 }} </ref>: | Additional clinical clues that suggest renal artery disease are listed below<ref name="pmid15114537">{{cite journal| author=Kidney Disease Outcomes Quality Initiative (K/DOQI)| title=K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. | journal=Am J Kidney Dis | year= 2004 | volume= 43 | issue= 5 Suppl 1 | pages= S1-290 | pmid=15114537 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15114537 }} </ref>: | ||
*Age of hypertension < 30 years and > 55 years | *Age of [[hypertension]] < 30 years and > 55 years | ||
*Abrupt onset of hypertension | *Abrupt onset of [[hypertension]] | ||
*Accelerated hypertension that was previously well-controlled | *Accelerated [[hypertension]] that was previously well-controlled | ||
*Refractory hypertension to 3 anti-hypertensive medications | *Refractory [[hypertension]] to 3 anti-hypertensive medications | ||
*Malignant hypertension | *[[Malignant hypertension]] | ||
*Smoking | *[[Smoking]] | ||
*Abdominal bruit | *Abdominal bruit | ||
*Flash pulmonary edema | *[[Flash pulmonary edema]] | ||
*Generalized atherosclerosis obliterans | *Generalized atherosclerosis obliterans | ||
*Asymmetric kidney sizes | *Asymmetric kidney sizes | ||
* | *[[Acute kidney injury]] when ACE-I or ARB are used for treatment | ||
==References== | ==References== | ||
Revision as of 01:23, 15 May 2014
|
Renal artery stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal artery stenosis history and symptoms On the Web |
|
American Roentgen Ray Society Images of Renal artery stenosis history and symptoms |
|
Risk calculators and risk factors for Renal artery stenosis history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian
Overview
Resistant hypertension and a decrease in estimated glomerular filtration rate (eGFR) in a patient known to have atherosclerosis are 3 elements that are very important to raise the suspicion of atherosclerotic renal artery stenosis. Other factors, such as hypertension at an early age or malignant hypertension, play a major role as well.
History and symptoms
According to the KDOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease[1], the most important clinical clues that should raise the suspicion of renal artery disease are the triad:
|
Additional clinical clues that suggest renal artery disease are listed below[1]:
- Age of hypertension < 30 years and > 55 years
- Abrupt onset of hypertension
- Accelerated hypertension that was previously well-controlled
- Refractory hypertension to 3 anti-hypertensive medications
- Malignant hypertension
- Smoking
- Abdominal bruit
- Flash pulmonary edema
- Generalized atherosclerosis obliterans
- Asymmetric kidney sizes
- Acute kidney injury when ACE-I or ARB are used for treatment
References
- ↑ 1.0 1.1 Kidney Disease Outcomes Quality Initiative (K/DOQI) (2004). "K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease". Am J Kidney Dis. 43 (5 Suppl 1): S1–290. PMID 15114537.